Print page Close print preview
Logo Going International
Accedi a banche dati online | Convegnodetail

Liquid Biopsy Surveillance and Early Detection Summit

Evvnt Promotion / evvnt
16.11.2022 - 17.11.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 07:30 - 16:00
Temi della conferenza
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail and AstraZeneca, Amgen and Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift. Touted as having the potential to transform clinical practice as we know it, technical progress and mounting investment in premetastatic applications are creating huge industry-wide excitement for liquid biopsy-based screening and surveillance for novel precision drug development.
Professional congress organizer (PCO)
Hanson Wade

Speakers: Aadel Chaudhuri, Assistant Professor of Radiation Oncology, Washington University School of Medicine, and more.

Informazioni ed Iscrizioni:
Mr. Alex Domingo
Medicina General
Quote del Congresso
Drug Developers and Academics Conference Pass: USD 0.50, Commercial Vendors Conference Pass: USD 3599.00, Technical Vendors Conference Pass: USD 2599.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom